A detailed history of Jane Street Group, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 126,085 shares of KURA stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,085
Previous 92,237 36.7%
Holding current value
$1.36 Million
Previous $1.9 Million 29.7%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.57 - $23.23 $628,557 - $786,289
33,848 Added 36.7%
126,085 $2.46 Million
Q2 2024

Aug 14, 2024

SELL
$17.53 - $22.98 $1.22 Million - $1.6 Million
-69,836 Reduced 43.09%
92,237 $1.9 Million
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $855,632 - $1.5 Million
63,758 Added 64.85%
162,073 $3.46 Million
Q4 2023

Feb 14, 2024

BUY
$7.58 - $14.38 $745,227 - $1.41 Million
98,315 New
98,315 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $221,856 - $322,637
23,062 Added 32.95%
93,053 $984,000
Q1 2023

May 15, 2023

BUY
$10.71 - $14.6 $628,698 - $857,049
58,702 Added 519.99%
69,991 $855,000
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $159,802 - $240,486
-14,230 Reduced 55.76%
11,289 $140,000
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $86,303 - $139,767
7,186 Added 39.2%
25,519 $349,000
Q2 2022

Aug 16, 2022

BUY
$10.71 - $18.33 $86,290 - $147,684
8,057 Added 78.41%
18,333 $336,000
Q1 2022

May 17, 2022

SELL
$11.78 - $16.98 $37,307 - $53,775
-3,167 Reduced 23.56%
10,276 $165,000
Q4 2021

Feb 15, 2022

SELL
$12.22 - $19.57 $80,676 - $129,201
-6,602 Reduced 32.94%
13,443 $188,000
Q2 2021

Aug 16, 2021

SELL
$20.85 - $29.88 $44,535 - $63,823
-2,136 Reduced 9.63%
20,045 $418,000
Q1 2021

May 18, 2021

SELL
$24.75 - $39.14 $790,515 - $1.25 Million
-31,940 Reduced 59.02%
22,181 $627,000
Q4 2020

Feb 17, 2021

BUY
$29.0 - $41.62 $1.09 Million - $1.56 Million
37,586 Added 227.31%
54,121 $1.77 Million
Q3 2020

Nov 17, 2020

BUY
$16.3 - $30.64 $269,520 - $506,632
16,535 New
16,535 $507,000
Q1 2020

May 15, 2020

SELL
$6.45 - $14.04 $206,374 - $449,223
-31,996 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$12.97 - $15.94 $414,988 - $510,016
31,996 New
31,996 $440,000
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $201,013 - $284,416
-13,628 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$14.71 - $19.79 $200,467 - $269,698
13,628 New
13,628 $268,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $722M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.